Search the Appendices of Resolution CM/Res(2018)1
1676 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
CAPMATINIB | L01EX17 | DE | POM | 27-02-2023 | EMEA/H/C/004845 | 20-06-2022 | VALID | |
AVAPRITINIB | L01EX18 | DE | POM | 18-01-2021 | EMEA/H/C/005208 | 24-09-2020 | VALID | |
RIPRETINIB | L01EX19 | DE | POM | 25-04-2022 | EMEA/H/C/005614 | 18-11-2021 | VALID | |
SELPERCATINIB | L01EX22 | DE | POM | 02-06-2021 | EMEA/H/C/005375 | 11-02-2021 | VALID | |
PRALSETINIB | L01EX23 | DE | POM | 25-04-2022 | EMEA/H/C/005413 | 18-11-2021 | VALID | |
CAPIVASERTIB | L01EX27 | DE | POM | 27-11-2024 | EMEA/H/C/006017 | 17-06-2024 | VALID | |
OFATUMUMAB | L01FA02 | DE | POM | VALID | ||||
OBINUTUZUMAB | L01FA03 | DE | POM | VALID | ||||
INOTUZUMAB OZOGAMICIN | L01FB01 | DE | POM | 20-11-2017 | EMEA/H/C/004119 | 29-06-2017 | VALID | |
MOXETUMOMAB PASUDOTOX | L01FB02 | DE | Not authorised | 02-06-2021 | VALID | |||
DARATUMUMAB | L01FC01 | DE | POM | VALID | ||||
ISATUXIMAB | L01FC02 | DE | POM | 22-12-2020 | EMEA/H/C/004977 | 30-05-2020 | VALID | |
PERTUZUMAB | L01FD02 | DE | POM | VALID | ||||
TRASTUZUMAB EMTANSINE | L01FD03 | DE | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | DE | Not authorised | 08-10-2021 | VALID | |||
PANITUMUMAB | L01FE02 | DE | POM | VALID | ||||
NECITUMUMAB | L01FE03 | DE | Not authorised | VALID | ||||
NIVOLUMAB | L01FF01 | DE | POM | VALID | ||||
PEMBROLIZUMAB | L01FF02 | DE | POM | VALID | ||||
DURVALUMAB | L01FF03 | DE | POM | 12-11-2018 | EMEA/H/C/004771 | 20-09-2018 | VALID | |
AVELUMAB | L01FF04 | DE | POM | VALID | ||||
ATEZOLIZUMAB | L01FF05 | DE | POM | EMEA/H/C/004143 | 21-09-2017 | VALID | ||
CEMIPLIMAB | L01FF06 | DE | POM | 22-04-2020 | EMEA/H/C/004844 | 27-06-2019 | VALID | |
DOSTARLIMAB | L01FF07 | DE | POM | 08-10-2021 | EMEA/H/C/005204 | 21-04-2021 | VALID | |
TISLELIZUMAB | L01FF09 | DE | POM | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
RETIFANLIMAB | L01FF10 | DE | POM | 27-11-2024 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
TORIPALIMAB | L01FF13 | DE | Not authorised | 27-11-2024 | VALID | |||
RAMUCIRUMAB | L01FG02 | DE | POM | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | DE | POM | 12-11-2018 | EMEA/H/C/004204 | 21-09-2018 | VALID | |
IPILIMUMAB | L01FX04 | DE | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | DE | POM | EMEA/H/C/003918 | 08-05-2017 | VALID | ||
BLINATUMOMAB | L01FX07 | DE | POM | VALID | ||||
ELOTUZUMAB | L01FX08 | DE | POM | VALID | ||||
MOGAMULIZUMAB | L01FX09 | DE | POM | 21-10-2019 | EMEA/H/C/004232 | 22-11-2018 | VALID | |
TAFASITAMAB | L01FX12 | DE | POM | 27-01-2022 | VALID | |||
ENFORTUMAB VEDOTIN | L01FX13 | DE | POM | 27-02-2023 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
POLATUZUMAB VEDOTIN | L01FX14 | DE | POM | 22-04-2020 | EMEA/H/C/004870 | 16-01-2020 | VALID | |
SACITUZUMAB GOVITECAN | L01FX17 | DE | POM | 25-04-2022 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
AMIVANTAMAB | L01FX18 | DE | POM | 25-04-2022 | EMEA/H/C/005454 | 09-12-2021 | VALID | |
TREMELIMUMAB | L01FX20 | DE | POM | 14-11-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | DE | POM | 14-11-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
GLOFITAMAB | L01FX28 | DE | POM | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
TALQUETAMAB | L01FX29 | DE | POM | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
ZOLBETUXIMAB | L01FX31 | DE | Not authorised | 27-11-2024 | VALID | |||
ELRANATAMAB | L01FX32 | DE | Not authorised | 13-05-2024 | VALID | |||
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | DE | POM | VALID | ||||
NIVOLUMAB AND RELATLIMAB | L01FY02 | DE | POM | 27-02-2023 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
CISPLATIN | L01XA01 | DE | POM | 21-10-2019 | ES/H/0507/001/MR | 09-02-2018 | VALID | |
CARBOPLATIN | L01XA02 | DE | Currently not available | DE/H/0803/001/ | 18-12-2014 | VALID | ||
OXALIPLATIN | L01XA03 | DE | I | DE/H/2769/001/ | 25-06-2012 | VALID |